Company / Capital Expenditures
AtriCure, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$9.1M
FY2025
5-year range
$9.1M / $16.9M
FY2021-FY2025
Trend
-21.0%
vs FY2024
Sector context
#111 of 145
Health Care
What the data says
AtriCure, Inc.'s capital expenditures of $9M is lower than 77% of companies in the Health Care sector (FY2025). Capital Expenditures has declined for 3 consecutive years, from $17M in FY2022 to $9M in FY2025.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of +11.5%.
Declined from $12M to $9M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -18.8%
- 5-Year CAGR
- +11.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 145This company $9.1M Sector average $268.6M
▼
-96.6% below sector average
Key checks
Key Insights
- AtriCure, Inc.'s capital expenditures has declined for 3 consecutive years.
- 5-year CAGR of +11.5%, indicating consistent growth.
- In FY2025, capital expenditures decreased 21.0% year-over-year.
- Ranks #111 out of 145 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -9.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.1M | -21.0% |
| FY2024 | $11.5M | -4.5% |
| FY2023 | $12.0M | -28.9% |
| FY2022 | $16.9M | +73.1% |
| FY2021 | $9.8M | +85.5% |
| FY2020 | $5.3M | -56.8% |
| FY2019 | $12.2M | +96.1% |
| FY2018 | $6.2M | -2.7% |
| FY2017 | $6.4M | -17.0% |
| FY2016 | $7.7M | -42.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026